Element Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Element Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-11,906	Closed	-$165K	–	816
2019 Q1	$165K	Buy	+11,906	New	+$136K	0.01%	776
2018 Q4	–	Sell	-34,426	Closed	-$435K	–	967
2018 Q3	$435K	Sell	34,426 -5,200	-13%	-$62.7K	0.01%	462
2018 Q2	$522K	Buy	39,626 +25,173	+174%	+$301K	0.01%	364
2018 Q1	$197K	Buy	+14,453	New	+$149K	﹤0.01%	691

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Element Capital Management's CCXI Position: Q2 2019 in Review

Element Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q2 2019, closing a stake of 11,906 shares — an estimated $165K sold.

Element Capital Management first reported a position in CCXI in Q1 2018 and held it in 4 quarters. The position peaked at $522K in Q2 2018. 117 funds tracked by Wall St. Rank hold CCXI as of Q2 2019.

Element Capital Management reported no remaining ChemoCentryx, Inc. position as of Q2 2019 after selling out during the quarter.
Element Capital Management sold 11,906 ChemoCentryx, Inc. shares in Q2 2019, an estimated $165K.
Element Capital Management first reported a position in ChemoCentryx, Inc. in Q1 2018 and held it in 4 quarters.
Element Capital Management's ChemoCentryx, Inc. position peaked at $522K in Q2 2018.
117 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2019.

Based on Element Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.